Angiotensin II also escalates the NAFLD to NASH progression and may then result in fibrosis by stimulation of fibroblasts and induction of pro-inflammatory cytokines [17]. The gene discussed is AGT; the disease is metabolic dysfunction-associated steatotic liver disease.